| Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer MJ Zelefsky, SA Leibel, PB Gaudin, GJ Kutcher, NE Fleshner, ... International Journal of Radiation Oncology* Biology* Physics 41 (3), 491-500, 1998 | 1235 | 1998 |
| Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA MC Liu, GR Oxnard, EA Klein, C Swanton, MV Seiden, MC Liu, ... Annals of Oncology 31 (6), 745-759, 2020 | 1046 | 2020 |
| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 815 | 2018 |
| Sensitive tumour detection and classification using plasma cell-free DNA methylomes SY Shen, R Singhania, G Fehringer, A Chakravarthy, MHA Roehrl, ... Nature 563 (7732), 579-583, 2018 | 736 | 2018 |
| Genomic hallmarks of localized, non-indolent prostate cancer M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ... Nature 541 (7637), 359-364, 2017 | 608 | 2017 |
| Active surveillance of small renal masses: progression patterns of early stage kidney cancer MAS Jewett, K Mattar, J Basiuk, CG Morash, SE Pautler, DR Siemens, ... European urology 60 (1), 39-44, 2011 | 565 | 2011 |
| Spatial genomic heterogeneity within localized, multifocal prostate cancer PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ... Nature genetics 47 (7), 736-745, 2015 | 531 | 2015 |
| Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen … R Choo, L Klotz, C Danjoux, GC Morton, G DeBoer, E Szumacher, ... The Journal of urology 167 (4), 1664-1669, 2002 | 422 | 2002 |
| Designing the selenium and vitamin E cancer prevention trial (SELECT) SM Lippman, PJ Goodman, EA Klein, HL Parnes, IM Thompson, ... Journal of the National Cancer Institute 97 (2), 94-102, 2005 | 407 | 2005 |
| Impact of androgen deprivation therapy on cardiovascular disease and diabetes SMH Alibhai, M Duong-Hua, R Sutradhar, NE Fleshner, P Warde, ... Journal of Clinical Oncology 27 (21), 3452-3458, 2009 | 384 | 2009 |
| Cancer-related fatigue and associated disability in post-treatment cancer survivors JM Jones, K Olson, P Catton, CN Catton, NE Fleshner, MK Krzyzanowska, ... Journal of Cancer Survivorship 10, 51-61, 2016 | 362 | 2016 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 345 | 2021 |
| Epidemiology and prevention of prostate cancer G Gandaglia, R Leni, F Bray, N Fleshner, SJ Freedland, A Kibel, P Stattin, ... European urology oncology 4 (6), 877-892, 2021 | 338 | 2021 |
| Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications MS Cookson, NE Fleshner, SM Soloway, WR Fair The Journal of urology 157 (2), 559-562, 1997 | 312 | 1997 |
| Metformin use and all-cause and prostate cancer–specific mortality among men with diabetes D Margel, DR Urbach, LL Lipscombe, CM Bell, G Kulkarni, PC Austin, ... Journal of Clinical Oncology 31 (25), 3069-3075, 2013 | 307 | 2013 |
| Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men AR Zlotta, S Egawa, D Pushkar, A Govorov, T Kimura, M Kido, ... Journal of the National Cancer Institute 105 (14), 1050-1058, 2013 | 305 | 2013 |
| Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic GS Kulkarni, T Hermanns, Y Wei, B Bhindi, R Satkunasivam, ... Journal of clinical oncology 35 (20), 2299-2305, 2017 | 296 | 2017 |
| Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study AV Rao, N Fleshner, S Agarwal Nutrition and cancer 33 (2), 159-164, 1999 | 249 | 1999 |
| 30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity SMH Alibhai, M Leach, G Tomlinson, MD Krahn, N Fleshner, E Holowaty, ... Journal of the National Cancer Institute 97 (20), 1525-1532, 2005 | 246 | 2005 |
| Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines AQ Haddad, V Venkateswaran, L Viswanathan, SJ Teahan, NE Fleshner, ... Prostate cancer and prostatic diseases 9 (1), 68-76, 2006 | 233 | 2006 |
